Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06035601 · ClinicalTrials.gov registry record · NA
EHR-integrated rUTI Texting Platform
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT06035601: Completed NA study, sponsored by University of Pennsylvania.
NCT06035601 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06035601, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care? Participants enrolled onto the texting platform will: • receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.
Interventions
- OTHER Usual care
- DEVICE EHR-integrated texting platform (Urotrust)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06035601
The ClinicalTrials.gov registry entry for NCT06035601 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT06035601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06035601 about?
NCT06035601 is a clinical study titled "EHR-integrated rUTI Texting Platform". The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics ...
What is the current status of trial NCT06035601?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2024-03-07. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT06035601?
The interventions under investigation include: Usual care (OTHER), EHR-integrated texting platform (Urotrust) (DEVICE).
Who is sponsoring clinical trial NCT06035601?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.